世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

前立腺の健康市場

前立腺の健康市場


Prostate Health Market

Future Market Insights社が発行したこの市場に関する最新調査では、2014年から2021年までの世界の産業分析と2022年から2032年までの機会評価を提供しています。この調査は、より重要な市場力学の包括的な評価を... もっと見る

 

 

出版社 出版年月 電子版価格 納期 ページ数 言語
Future Market Insights
フューチャーマーケットインサイツ
2022年2月14日 US$5,000
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
3-5営業日以内 309 英語

 

サマリー

Future Market Insights社が発行したこの市場に関する最新調査では、2014年から2021年までの世界の産業分析と2022年から2032年までの機会評価を提供しています。この調査は、より重要な市場力学の包括的な評価を提供しています。

前立腺健康市場の過去と現在の成長パラメータを徹底的に調査した後、市場の成長見通しを最大限の精度で得ることができます。

市場区分

本書は、市場のあらゆる側面をカバーし、読者に完全な市場情報を提供するため、詳細にセグメント化されています。

疾患別適応症

前立腺癌
前立腺肥大症(Benign Prostate Hyperplasia
前 立腺炎
地域別

北アメリカ
ラテンアメリカ
ヨーロッパ
アジア太平洋地域
中近東・アフリカ
報告書の章立て

第01章 - エグゼクティブサマリー

前立腺健康市場に関するエグゼクティブサマリーには、市場独自の輪切り、需要側と供給側の動向、機会評価、前立腺健康市場に関する提言が含まれています。

第02章 市場の概要

読者はこの章で前立腺健康市場の詳細なセグメンテーションと定義を知ることができ、前立腺健康市場の基本的な情報を理解することができます。また、この章では、読者が前立腺ヘルスの市場範囲を理解するのに役立つ、包含と除外を強調します。

第03章 市場の背景

このセクションでは、前立腺の健康市場の関連産業評価を実施します。前立腺健康市場の成長に影響を与えるマクロ経済的要因を提供し、これらのマクロ経済指標が前立腺健康市場に与える影響を分析します。前立腺健康市場における処理の概要と技術的進歩も提供します。

第04章 前立腺ヘルスの市場バリューチェーン

前立腺疾患市場の各レベルにおける利益率を分析し、読者は上位輸入業者と輸出業者、および前立腺疾患市場のバリューチェーンに関する詳細情報を得ることができます。

第05章 市場ダイナミクス

本章では、前立腺ヘルスの市場成長に影響を与えるドライバーと阻害要因について説明します。前立腺ヘルスの市場における機会や進行中のトレンドについても包括的に考察しています。

第06章 前立腺ヘルスの市場-価格分析

この章では、製品タイプ別に世界および地域の価格分析を行います。また、価格設定に影響を与える要因についても解説しています。2022年、2032年におけるメーカーレベル、販売店レベル、小売レベルの価格分析がご覧いただけます。

第07章 前立腺の健康市場の需要分析と予測 2022-2032年

本章では、過去の前立腺健康市場(2014年~2021年)の詳細な分析に加え、予測期間(2022年~2032年)の機会分析も行います。読者は、今年度(2022年)の絶対的な$の機会と予測期間(2022-2032年)の増分的な機会も見つけることができます。

第8章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年)

前立腺ヘルスの市場は、ロボットの種類によって、多関節型、直交型、円筒型、極型、スカラ型、デルタ型に分類されます。本章では、読者は前立腺健康市場における主要なトレンドと開発に関する情報、およびロボットタイプに基づく市場の魅力的な分析をご覧いただけます。

第9章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年)

ロボットシステムの種類に基づき、前立腺ヘルスの市場はマニピュレーションロボットシステム、モバイルロボットシステム、データ収集・制御ロボットシステムに区分されます。本章では、読者は前立腺健康市場の主要トレンドと開発に関する情報、およびロボットシステムタイプに基づく市場の魅力的な分析をご覧いただけます。

第10章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年)

前立腺ヘルスの市場は用途により、産業用ロボット、医療用ロボット、消費者用ロボットに区分されます。本章では、読者は前立腺健康市場における主要なトレンドと開発、アプリケーションに基づく市場の魅力的な分析に関する情報を得ることができます。

第11章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年)

前立腺ヘルスの市場は、提供方法によって標準品とカスタマイズ品に分類されます。本章では、読者は前立腺健康市場の主要な動向と発展に関する情報、およびオファリングに基づく市場の魅力的な分析をご覧いただくことができます。

第12章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年)

前立腺ヘルスの市場は、ソフトウェアに基づいて、ピック&プレース、ドリル、ホールド&ローテート、塗装、打撃、パンチング&ブランキング、溶接、検査、切断、レイアウト、マーキング&計測、研削&研磨、その他に分類されます。この章では、読者が前立腺健康市場の主要な動向と発展、ソフトウェアに基づく市場の魅力的な分析に関する情報を得ることができます。

第13章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年)

前立腺ヘルスの市場は、モーションタイプにより、リニア、ロータリー、オシレート、全方位に区分されます。本章では、前立腺ヘルスの主要トレンドと開発に関する情報、モーションタイプに基づく市場の魅力的な分析について紹介します。

第14章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年)

前立腺ヘルスの市場は、最終用途に基づき、製造業、石油・ガス、ヘルスケア、研究アカデミア、その他に区分されます。本章では、読者が前立腺健康市場の主要な動向と発展、および最終用途に基づく市場の魅力的な分析に関する情報を得ることができます。

第15章 前立腺ヘルスの世界市場分析(2014年~2021年)&機会評価(2022年~2032年)

本章では、北米、中南米、西ヨーロッパ、東ヨーロッパ、東南アジア&太平洋、中国、インド、日本、中東&アフリカ(MEA)など、さまざまな地域にわたって前立腺ヘルスの市場がどのように成長するのかを解説します。

第16章 北米前立腺ヘルスの市場分析 2014-2021年&機会評価 2022-2032年

本章では、北米の前立腺疾患市場の成長について、米国やカナダなど国別の評価とともに詳細に分析します。また、北米におけるロボットタイプ、ロボットシステムタイプ、アプリケーション、オファリング、ソフトウェア、モーションタイプ、エンドユース、ロボットにおけるモーションコントロールソフトウェアの国別に地域動向と市場成長をご覧いただけます。

第17章 ラテンアメリカの前立腺健康市場分析2014-2021年&機会評価2022-2032年

読者は、中南米前立腺健康市場の成長に影響を与える要因、価格分析、地域動向などの詳細な情報を得ることができます。本章では、ブラジル、メキシコ、その他のラテンアメリカ地域など、ラテンアメリカの主要国における前立腺健康市場の成長展望も記載しています。

第18章 東欧の前立腺ヘルスの市場分析 2014-2021年&予測 2022-2032年

本章では、ポーランド、チェコ、その他の東欧諸国を含む国別の評価とともに、東欧の前立腺疾患市場の成長について詳しく分析します。読者は、東欧の国々に基づく価格分析、地域動向、市場成長もご覧いただけます。

第19章 西ヨーロッパ前立腺ヘルスの市場分析 2014-2021年&予測 2022-2032年

本章では、西欧の前立腺疾患市場の成長について、イギリス、フランス、ドイツ、その他の西欧諸国を含む国別の評価とともに詳細に分析します。読者は、西ヨーロッパの国々に基づく価格分析、地域動向、市場成長もご覧いただけます。

第20章 APEJ前立腺ヘルスの市場分析 2014-2021年&機会評価 2022-2032年

読者は、2022年から2032年までのAPEJ前立腺健康市場の成長パラメータに関する徹底的な情報を得ることができます。

第21章 日本前立腺医療市場分析 2014-2021年&機会評価 2022-2032年

読者は、市場セグメンテーションに基づき、予測期間中に日本における前立腺健康市場の成長に大きな影響を与える重要な要因を見つけることができます。本章では、日本の前立腺疾患市場の促進要因、阻害要因、トレンドの概要を説明します。

第22章 MEA前立腺健康市場分析 2014-2021年&機会評価 2022-2032年

本章では、2022年から2032年の間に、GCC諸国、南アフリカ、その他のMEA地域などのMEA地域の主要国で前立腺健康市場がどのように成長するのかについての情報を提供します。

第23章 競争環境、企業シェア、企業プロファイル

本章では、前立腺健康市場における主要なステークホルダーを網羅的にリストアップするとともに、各企業に関する詳細情報(企業概要、売上シェア、戦略的概要、最近の企業動向など)を掲載しています。

第24章 前提条件と頭字語

この章では、レポートに含まれる情報や統計の根拠となる略語や仮定をリストアップしています。

第25章 調査方法

本章では、前立腺健康市場に関する様々な結論、重要な定性情報、定量情報を得るために行った調査方法について読者の理解を助ける。

ページTOPに戻る


目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Fact.MR Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Prostate Health Demand

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

4.1. Global Prostate Health Market (US$ Mn)

4.2. Prostate Health Market Opportunity Assessment (US$ Mn)

4.2.1. Total Available Market

4.2.2. Serviceable Addressable Market

4.2.3. Serviceable Obtainable Market

4.3. Market Scenario Forecast

4.3.1. Demand in optimistic Scenario

4.3.2. Demand in Likely Scenario

4.3.3. Demand in Conservative Scenario

4.4. Investment Feasibility Analysis

4.4.1. Investment in Established Markets

4.4.1.1. In Short Term

4.4.1.2. In Long Term

4.4.2. Investment in Emerging Markets

4.4.2.1. In Short Term

4.4.2.2. In Long Term

4.5. Forecast Factors - Relevance & Impact

4.5.1. Top Companies Historical Growth

4.5.2. Global Prostate Health Market Growth

4.5.3. Prostate Health Adoption Rate, by Country

4.6. Market Dynamics

4.6.1. Market Driving Factors and Impact Assessment

4.6.2. Prominent Market Challenges and Impact Assessment

4.6.3. Prostate Health Market Opportunities

4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

5.2. Banking on with Segments High Incremental Opportunity

5.3. Peer Benchmarking

6. Global Prostate Health Market Demand Analysis 2015-2021 and Forecast, 2022-2032

6.1. Historical Market Analysis, 2015-2021

6.2. Current and Future Market Projections, 2022-2032

6.3. Y-o-Y Growth Trend Analysis

7. Global Prostate Health Market Value Analysis 2015-2021 and Forecast, 2022-2032

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Indication

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2015-2021

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032

8.3.1. Prostate Cancer

8.3.1.1. AR Directed Therapies

8.3.1.2. Hormone ADT

8.3.1.3. Cytotoxic Agents

8.3.1.4. PARP Inhibitors

8.3.1.5. Others

8.3.2. Benign Prostate Hyperplasia

8.3.2.1. Alpha Blockers

8.3.2.1.1. Alfuzosin

8.3.2.1.2. Doxazosin

8.3.2.1.3. Tamsulosin

8.3.2.1.4. Silodosin

8.3.2.1.5. Other Alpha Blockers

8.3.2.2. 5 Alpha Reductase

8.3.2.2.1. Finasteride

8.3.2.2.2. Dutasteride

8.3.2.3. Others

8.3.3. Prostatitis

8.3.3.1. Prescription

8.3.3.2. Over the Counter

8.4. Market Attractiveness Analysis By Disease Indication

9. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. Asia Pacific

9.3.5. Middle East and Africa (MEA)

9.4. Market Attractiveness Analysis By Region

10. North America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

10.1. Introduction

10.2. Pricing Analysis

10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

10.4.1. By Country

10.4.1.1. U.S.

10.4.1.2. Canada

10.4.2. By Disease Indication

10.5. Market Attractiveness Analysis

10.5.1. By Country

10.5.2. By Disease Indication

11. Latin America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

11.1. Introduction

11.2. Pricing Analysis

11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

11.4.1. By Country

11.4.1.1. Brazil

11.4.1.2. Mexico

11.4.1.3. Rest of Latin America

11.4.2. By Disease Indication

11.5. Market Attractiveness Analysis

11.5.1. By Country

11.5.2. By Disease Indication

12. Europe Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

12.1. Introduction

12.2. Pricing Analysis

12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

12.4.1. By Country

12.4.1.1. Germany

12.4.1.2. France

12.4.1.3. U.K.

12.4.1.4. Italy

12.4.1.5. Benelux

12.4.1.6. Nordic Countries

12.4.1.7. Rest of Europe

12.4.2. By Disease Indication

12.5. Market Attractiveness Analysis

12.5.1. By Country

12.5.2. By Disease Indication

13. Asia Pacific Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

13.1. Introduction

13.2. Pricing Analysis

13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

13.4.1. By Country

13.4.1.1. China

13.4.1.2. Japan

13.4.1.3. South Korea

13.4.1.4. Rest of Asia Pacific

13.4.2. By Disease Indication

13.5. Market Attractiveness Analysis

13.5.1. By Country

13.5.2. By Disease Indication

14. Middle East and Africa Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

14.4.1. By Country

14.4.1.1. GCC Countries

14.4.1.2. South Africa

14.4.1.3. Turkey

14.4.1.4. Rest of Middle East and Africa

14.4.2. By Disease Indication

14.5. Market Attractiveness Analysis

14.5.1. By Country

14.5.2. By Disease Indication

15. Key Countries Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

15.1. Introduction

15.1.1. Market Value Proportion Analysis, By Key Countries

15.1.2. Global Vs. Country Growth Comparison

15.2. US Prostate Health Market Analysis

15.2.1. Value Proportion Analysis by Market Taxonomy

15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.2.2.1. By Disease Indication

15.3. Canada Prostate Health Market Analysis

15.3.1. Value Proportion Analysis by Market Taxonomy

15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.3.2.1. By Disease Indication

15.4. Mexico Prostate Health Market Analysis

15.4.1. Value Proportion Analysis by Market Taxonomy

15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.4.2.1. By Disease Indication

15.5. Brazil Prostate Health Market Analysis

15.5.1. Value Proportion Analysis by Market Taxonomy

15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.5.2.1. By Disease Indication

15.6. Germany Prostate Health Market Analysis

15.6.1. Value Proportion Analysis by Market Taxonomy

15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.6.2.1. By Disease Indication

15.7. France Prostate Health Market Analysis

15.7.1. Value Proportion Analysis by Market Taxonomy

15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.7.2.1. By Disease Indication

15.8. Italy Prostate Health Market Analysis

15.8.1. Value Proportion Analysis by Market Taxonomy

15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.8.2.1. By Disease Indication

15.9. BENELUX Prostate Health Market Analysis

15.9.1. Value Proportion Analysis by Market Taxonomy

15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.9.2.1. By Disease Indication

15.10. UK Prostate Health Market Analysis

15.10.1. Value Proportion Analysis by Market Taxonomy

15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.10.2.1. By Disease Indication

15.11. Nordic Countries Prostate Health Market Analysis

15.11.1. Value Proportion Analysis by Market Taxonomy

15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.11.2.1. By Disease Indication

15.12. China Prostate Health Market Analysis

15.12.1. Value Proportion Analysis by Market Taxonomy

15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.12.2.1. By Disease Indication

15.13. Japan Prostate Health Market Analysis

15.13.1. Value Proportion Analysis by Market Taxonomy

15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.13.2.1. By Disease Indication

15.14. South Korea Prostate Health Market Analysis

15.14.1. Value Proportion Analysis by Market Taxonomy

15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.14.2.1. By Disease Indication

15.15. GCC Countries Prostate Health Market Analysis

15.15.1. Value Proportion Analysis by Market Taxonomy

15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.15.2.1. By Disease Indication

15.16. South Africa Prostate Health Market Analysis

15.16.1. Value Proportion Analysis by Market Taxonomy

15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.16.2.1. By Disease Indication

15.17. Turkey Prostate Health Market Analysis

15.17.1. Value Proportion Analysis by Market Taxonomy

15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.17.2.1. By Disease Indication

15.17.3. Competition Landscape and Player Concentration in the Country

16. Market Structure Analysis

16.1. Market Analysis by Tier of Companies

16.2. Market Concentration

16.3. Market Share Analysis of Top Players

16.4. Market Presence Analysis

16.4.1. By Regional footprint of Players

16.4.2. Product footprint by Players

17. Competition Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Competition Deep Dive

17.3.1. GLAXOSMITHKLINE

17.3.1.1. Overview

17.3.1.2. Product Portfolio

17.3.1.3. Sales Footprint

17.3.1.4. Strategy Overview

17.3.2. ASTELLAS PHARMA

17.3.2.1. Overview

17.3.2.2. Product Portfolio

17.3.2.3. Sales Footprint

17.3.2.4. Strategy Overview

17.3.3. ALLERGAN

17.3.3.1. Overview

17.3.3.2. Product Portfolio

17.3.3.3. Sales Footprint

17.3.3.4. Strategy Overview

17.3.4. MERCK

17.3.4.1. Overview

17.3.4.2. Product Portfolio

17.3.4.3. Sales Footprint

17.3.4.4. Strategy Overview

17.3.5. ELI LILLY AND COMPANY

17.3.5.1. Overview

17.3.5.2. Product Portfolio

17.3.5.3. Sales Footprint

17.3.5.4. Strategy Overview

17.3.6. ABBOTT LABORATORIES

17.3.6.1. Overview

17.3.6.2. Product Portfolio

17.3.6.3. Sales Footprint

17.3.6.4. Strategy Overview

17.3.7. JOHNSON & JOHNSON SERVICES, INC.

17.3.7.1. Overview

17.3.7.2. Product Portfolio

17.3.7.3. Sales Footprint

17.3.7.4. Strategy Overview

17.3.8. ABBVIE

17.3.8.1. Overview

17.3.8.2. Product Portfolio

17.3.8.3. Sales Footprint

17.3.8.4. Strategy Overview

17.3.9. SANOFI

17.3.9.1. Overview

17.3.9.2. Product Portfolio

17.3.9.3. Sales Footprint

17.3.9.4. Strategy Overview

17.3.10. PFIZER, INC.

17.3.10.1. Overview

17.3.10.2. Product Portfolio

17.3.10.3. Sales Footprint

17.3.10.4. Strategy Overview

18. Assumptions and Acronyms Used

19. Research Methodology


Table 1: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 2: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 3: Global Prostate Health Market, By Region, 2015 – 2021

Table 4: Global Prostate Health Market, By Region, 2022 – 2032

Table 5: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 6: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 7: North America Prostate Health Market, By Country, 2015 – 2021

Table 8: North America Prostate Health Market, By Country, 2022 – 2032

Table 9: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 10: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 11: Latin America Prostate Health Market, By Country, 2015 – 2021

Table 12: Latin America Prostate Health Market, By Country, 2022 – 2032

Table 13: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 14: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 15: Europe Prostate Health Market, By Country, 2015 – 2021

Table 16: Europe Prostate Health Market, By Country, 2022 – 2032

Table 17: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 18: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 19: Asia Pacific Prostate Health Market, By Country, 2015 – 2021

Table 20: Asia Pacific Prostate Health Market, By Country, 2022 – 2032

Table 21: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 22: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 23: MEA Prostate Health Market, By Country, 2015 – 2021

Table 24: MEA Prostate Health Market, By Country, 2022 – 2032

Table 25: Global Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 26: Global Prostate Health Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 27: North America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 28: North America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 29: Latin America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 30: Latin America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 31: Europe Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 32: Europe Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 33: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 34: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 35: MEA Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 36: MEA Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032


Figure 1: Global Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Prostate Health Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 4: Global Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 5: Global Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 6: Global Prostate Health Market Share, By Region, 2022 & 2032

Figure 7: Global Prostate Health Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 8: Global Prostate Health Market Attractiveness Index, By Region – 2022-2032

Figure 9: North America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 10: North America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 11: North America Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 12: North America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 13: North America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 14: North America Prostate Health Market Share, By Country, 2022 & 2032

Figure 15: North America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 16: North America Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 17: Latin America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 18: Latin America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 19: Latin America Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 20: Latin America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 21: Latin America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 22: Latin America Prostate Health Market Share, By Country, 2022 & 2032

Figure 23: Latin America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 24: Latin America Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 25: Europe Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 26: Europe Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 27: Europe Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 28: Europe Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 29: Europe Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 30: Europe Prostate Health Market Share, By Country, 2022 & 2032

Figure 31: Europe Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 32: Europe Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 33: MEA Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 34: MEA Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 35: MEA Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 36: MEA Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 37: MEA Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 38: MEA Prostate Health Market Share, By Country, 2022 & 2032

Figure 39: MEA Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 40: MEA Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 41: Asia Pacific Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 42: Asia Pacific Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 43: Asia Pacific Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 44: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 45: Asia Pacific Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 46: Asia Pacific Prostate Health Market Share, By Country, 2022 & 2032

Figure 47: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 48: Asia Pacific Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 49: US Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 50: US Prostate Health Market Share, By Disease Indication, 2021

Figure 51: Canada Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 52: Canada Prostate Health Market Share, By Disease Indication, 2021

Figure 53: Brazil Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 54: Brazil Prostate Health Market Share, By Disease Indication, 2021

Figure 55: Mexico Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 56: Mexico Prostate Health Market Share, By Disease Indication, 2021

Figure 57: Germany Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 58: Germany Prostate Health Market Share, By Disease Indication, 2021

Figure 59: U.K. Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 60: U.K. Prostate Health Market Share, By Disease Indication, 2021

Figure 61: France Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 62: France Prostate Health Market Share, By Disease Indication, 2021

Figure 63: Italy Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 64: Italy Prostate Health Market Share, By Disease Indication, 2021

Figure 65: BENELUX Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 66: BENELUX Prostate Health Market Share, By Disease Indication, 2021

Figure 67: Nordic Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 68: Nordic Countries Prostate Health Market Share, By Disease Indication, 2021

Figure 69: China Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 70: China Prostate Health Market Share, By Disease Indication, 2021

Figure 71: Japan Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 72: Japan Prostate Health Market Share, By Disease Indication, 2021

Figure 73: South Korea Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 74: South Korea Prostate Health Market Share, By Disease Indication, 2021

Figure 75: GCC Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 76: GCC Countries Prostate Health Market Share, By Disease Indication, 2021

Figure 77: South Africa Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 78: South Africa Prostate Health Market Share, By Disease Indication, 2021

Figure 79: Turkey Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 80: Turkey Prostate Health Market Share, By Disease Indication, 2021

 

ページTOPに戻る


 

Summary

A recent market study published by Future Market Insights on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics.

After conducting thorough research on the historical and current growth parameters of the Prostate Health Market, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

The is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

By Disease Indication

Prostate Cancer
Benign Prostate Hyperplasia
Prostatitis
By Region

North America
Latin America
Europe
Asia Pacific
Middle East and Africa
Report Chapters

Chapter 01 – Executive Summary

The executive summary of the Prostate Health Market includes the market proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the Prostate Health Market.

Chapter 02 – Market Overview

Readers can find the detailed segmentation and definition of the Prostate Health Market in this chapter, which will help them understand basic information about the Prostate Health Market. This section also highlights the inclusions and exclusions, which help the reader, understand the scope of the Prostate Health Market report.

Chapter 03 – Market Background

The associated industry assessment of the Prostate Health Market is carried out in this section. The macroeconomic factors affecting the growth of the Prostate Health Market are provided in this section and the impact of these macroeconomic indicators on the Prostate Health Market is analyzed. The processing overview and technological advancements in the Prostate Health Market are also provided.

Chapter 04 – Prostate Health Market Value Chain

Profit margins at each level of the Prostate Health Market are analyzed and readers can find detailed information on top importers and exporters as well as the value chain of the Prostate Health Market.

Chapter 05 – Market Dynamics

The drivers and restraints impacting the growth of the Prostate Health Market are explained in this chapter. Opportunities and ongoing trends in the Prostate Health Market are also comprehensively discussed.

Chapter 06 – Prostate Health Market - Pricing Analysis

This chapter includes global as well as regional pricing analysis by product type. The pricing influencing factors are also explained in this chapter. The readers can understand the manufacturer level, distributor level as well as retail level pricing analysis for 2022 and 2032.

Chapter 07 – Prostate Health Market Demand Analysis and Forecast 2022-2032

This chapter includes a detailed analysis of the historical Prostate Health Market (2014-2021), along with an opportunity analysis for the forecast period (2022-2032). Readers can also find the absolute $ opportunity for the current year (2022) and incremental opportunity for the forecast period (2022-2032).

Chapter 8 – Global Prostate Health Market Analysis (2014-2021) & Opportunity Assessment (2022-2032)

Based on the robot type, the Prostate Health Market is segmented into articulated, cartesian, cylindrical, polar, SCARA and delta. In this chapter, readers can find information about key trends and developments in the Prostate Health Market and market attractive analysis based on the robot type.

Chapter 9 – Global Prostate Health Market Analysis (2014-2021) & Opportunity Assessment (2022-2032)

Based on the robotic system type, the Prostate Health Market is segmented into manipulation robotic system, mobile robotic system and data acquisition and control robotic system. In this chapter, readers can find information about key trends and developments in the Prostate Health Market and market attractive analysis based on the robotic system type.

Chapter 10 – Global Prostate Health Market Analysis (2014-2021) & Opportunity Assessment (2022-2032)

Based on the application, the Prostate Health Market is segmented into industrial robot, medical robot and consumer robot. In this chapter, readers can find information about key trends and developments in the Prostate Health Market and market attractive analysis based on application.

Chapter 11 – Global Prostate Health Market Analysis (2014-2021) & Opportunity Assessment (2022-2032)

Based on offering, the Prostate Health Market is segmented into standard and customized. In this chapter, readers can find information about key trends and developments in the Prostate Health Market and market attractive analysis based on the offering.

Chapter 12 – Global Prostate Health Market Analysis (2014-2021) & Opportunity Assessment (2022-2032)

Based on the software, the Prostate Health Market is segmented into pick & place, drilling, hold & rotate, painting, striking, punching & blanking, welding, inspection, cutting, layout, marking & measurement, grinding & polishing and other. In this chapter, readers can find information about key trends and developments in the Prostate Health Market and market attractive analysis based on the software.

Chapter 13 – Global Prostate Health Market Analysis (2014-2021) & Opportunity Assessment (2022-2032)

Based on the motion type, the Prostate Health Market is segmented into linear, rotary, oscillatory and omni-directional. In this chapter, readers can find information about key trends and developments in the Prostate Health Market and market attractive analysis based on the motion type.

Chapter 14 – Global Prostate Health Market Analysis (2014-2021) & Opportunity Assessment (2022-2032)

Based on the end use, the Prostate Health Market is segmented into manufacturing industries, oil & gas, healthcare, research academia and others. In this chapter, readers can find information about key trends and developments in the Prostate Health Market and market attractive analysis based on the end use.

Chapter 15 – Global Prostate Health Market Analysis (2014-2021) & Opportunity Assessment (2022-2032)

This chapter explains how the Prostate Health Market will grow across various geographic regions, such as North America, Latin America, Western Europe, Eastern Europe, Southeast Asia & Pacific, China, India, Japan and the Middle East & Africa (MEA).

Chapter 16 – North America Prostate Health Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

This chapter includes detailed analysis of the growth of the North America Prostate Health Market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends and market growth based on robot type, robotic system type, application, offering, software, motion type, end use, and country of motion control software in robotics in North America.

Chapter 17 – Latin America Prostate Health Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

Readers can find detailed information about factors such as, pricing analysis, and regional trends that are impacting the growth of the Latin America Prostate Health Market. This chapter also includes the growth prospects of the Prostate Health Market in leading LATAM countries such as Brazil, Mexico, and rest of the Latin America region.

Chapter 18 – Eastern Europe Prostate Health Market Analysis 2014-2021 & Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the Eastern Europe Prostate Health Market, along with a country-wise assessment that includes Poland, Czech Republic and Rest of Eastern Europe. Readers can also find the pricing analysis, regional trends, and market growth based on countries in Eastern Europe.

Chapter 19 – Western Europe Prostate Health Market Analysis 2014-2021 & Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the Western Europe Prostate Health Market, along with a country-wise assessment that includes the U.K., France, Germany and Rest of Western Europe. Readers can also find the pricing analysis, regional trends, and market growth based on countries in Western Europe.

Chapter 20 – APEJ Prostate Health Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

Readers can find thorough information about the growth parameters of the APEJ Prostate Health Market during the period 2022-2032.

Chapter 21 – Japan Prostate Health Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

Readers can find important factors that can make a huge impact on the growth of the Prostate Health Market in Japan based on the market segmentation, during the forecast period. This chapter provides the overview of drivers, restraints, and trends in the Japan Prostate Health Market.

Chapter 22 – MEA Prostate Health Market Analysis 2014-2021 & Opportunity Assessment 2022-2032

This chapter provides information on how the Prostate Health Market will grow in the major countries in MEA region, such as GCC Countries, South Africa and Rest of MEA during the period 2022-2032.

Chapter 23 – Competition Landscape, Company Share and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Prostate Health Market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments.

Chapter 24 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 25 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Prostate Health Market.



ページTOPに戻る


Table of Contents

1. Executive Summary

1.1. Global Market Outlook

1.2. Summary of Statistics

1.3. Key Market Characteristics & Attributes

1.4. Fact.MR Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

3.1. Risk Assessment

3.1.1. COVID-19 Crisis and Impact on Prostate Health Demand

3.1.2. COVID-19 Impact Benchmark with Previous Crisis

3.1.3. Impact on Market Value (US$ Mn)

3.1.4. Assessment by Key Countries

3.1.5. Assessment by Key Market Segments

3.1.6. Action Points and Recommendation for Suppliers

3.2. Key Trends Impacting the Market

3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

4.1. Global Prostate Health Market (US$ Mn)

4.2. Prostate Health Market Opportunity Assessment (US$ Mn)

4.2.1. Total Available Market

4.2.2. Serviceable Addressable Market

4.2.3. Serviceable Obtainable Market

4.3. Market Scenario Forecast

4.3.1. Demand in optimistic Scenario

4.3.2. Demand in Likely Scenario

4.3.3. Demand in Conservative Scenario

4.4. Investment Feasibility Analysis

4.4.1. Investment in Established Markets

4.4.1.1. In Short Term

4.4.1.2. In Long Term

4.4.2. Investment in Emerging Markets

4.4.2.1. In Short Term

4.4.2.2. In Long Term

4.5. Forecast Factors - Relevance & Impact

4.5.1. Top Companies Historical Growth

4.5.2. Global Prostate Health Market Growth

4.5.3. Prostate Health Adoption Rate, by Country

4.6. Market Dynamics

4.6.1. Market Driving Factors and Impact Assessment

4.6.2. Prominent Market Challenges and Impact Assessment

4.6.3. Prostate Health Market Opportunities

4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

5.2. Banking on with Segments High Incremental Opportunity

5.3. Peer Benchmarking

6. Global Prostate Health Market Demand Analysis 2015-2021 and Forecast, 2022-2032

6.1. Historical Market Analysis, 2015-2021

6.2. Current and Future Market Projections, 2022-2032

6.3. Y-o-Y Growth Trend Analysis

7. Global Prostate Health Market Value Analysis 2015-2021 and Forecast, 2022-2032

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Indication

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2015-2021

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032

8.3.1. Prostate Cancer

8.3.1.1. AR Directed Therapies

8.3.1.2. Hormone ADT

8.3.1.3. Cytotoxic Agents

8.3.1.4. PARP Inhibitors

8.3.1.5. Others

8.3.2. Benign Prostate Hyperplasia

8.3.2.1. Alpha Blockers

8.3.2.1.1. Alfuzosin

8.3.2.1.2. Doxazosin

8.3.2.1.3. Tamsulosin

8.3.2.1.4. Silodosin

8.3.2.1.5. Other Alpha Blockers

8.3.2.2. 5 Alpha Reductase

8.3.2.2.1. Finasteride

8.3.2.2.2. Dutasteride

8.3.2.3. Others

8.3.3. Prostatitis

8.3.3.1. Prescription

8.3.3.2. Over the Counter

8.4. Market Attractiveness Analysis By Disease Indication

9. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. Asia Pacific

9.3.5. Middle East and Africa (MEA)

9.4. Market Attractiveness Analysis By Region

10. North America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

10.1. Introduction

10.2. Pricing Analysis

10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

10.4.1. By Country

10.4.1.1. U.S.

10.4.1.2. Canada

10.4.2. By Disease Indication

10.5. Market Attractiveness Analysis

10.5.1. By Country

10.5.2. By Disease Indication

11. Latin America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

11.1. Introduction

11.2. Pricing Analysis

11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

11.4.1. By Country

11.4.1.1. Brazil

11.4.1.2. Mexico

11.4.1.3. Rest of Latin America

11.4.2. By Disease Indication

11.5. Market Attractiveness Analysis

11.5.1. By Country

11.5.2. By Disease Indication

12. Europe Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

12.1. Introduction

12.2. Pricing Analysis

12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

12.4.1. By Country

12.4.1.1. Germany

12.4.1.2. France

12.4.1.3. U.K.

12.4.1.4. Italy

12.4.1.5. Benelux

12.4.1.6. Nordic Countries

12.4.1.7. Rest of Europe

12.4.2. By Disease Indication

12.5. Market Attractiveness Analysis

12.5.1. By Country

12.5.2. By Disease Indication

13. Asia Pacific Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

13.1. Introduction

13.2. Pricing Analysis

13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

13.4.1. By Country

13.4.1.1. China

13.4.1.2. Japan

13.4.1.3. South Korea

13.4.1.4. Rest of Asia Pacific

13.4.2. By Disease Indication

13.5. Market Attractiveness Analysis

13.5.1. By Country

13.5.2. By Disease Indication

14. Middle East and Africa Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

14.1. Introduction

14.2. Pricing Analysis

14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

14.4.1. By Country

14.4.1.1. GCC Countries

14.4.1.2. South Africa

14.4.1.3. Turkey

14.4.1.4. Rest of Middle East and Africa

14.4.2. By Disease Indication

14.5. Market Attractiveness Analysis

14.5.1. By Country

14.5.2. By Disease Indication

15. Key Countries Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

15.1. Introduction

15.1.1. Market Value Proportion Analysis, By Key Countries

15.1.2. Global Vs. Country Growth Comparison

15.2. US Prostate Health Market Analysis

15.2.1. Value Proportion Analysis by Market Taxonomy

15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.2.2.1. By Disease Indication

15.3. Canada Prostate Health Market Analysis

15.3.1. Value Proportion Analysis by Market Taxonomy

15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.3.2.1. By Disease Indication

15.4. Mexico Prostate Health Market Analysis

15.4.1. Value Proportion Analysis by Market Taxonomy

15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.4.2.1. By Disease Indication

15.5. Brazil Prostate Health Market Analysis

15.5.1. Value Proportion Analysis by Market Taxonomy

15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.5.2.1. By Disease Indication

15.6. Germany Prostate Health Market Analysis

15.6.1. Value Proportion Analysis by Market Taxonomy

15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.6.2.1. By Disease Indication

15.7. France Prostate Health Market Analysis

15.7.1. Value Proportion Analysis by Market Taxonomy

15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.7.2.1. By Disease Indication

15.8. Italy Prostate Health Market Analysis

15.8.1. Value Proportion Analysis by Market Taxonomy

15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.8.2.1. By Disease Indication

15.9. BENELUX Prostate Health Market Analysis

15.9.1. Value Proportion Analysis by Market Taxonomy

15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.9.2.1. By Disease Indication

15.10. UK Prostate Health Market Analysis

15.10.1. Value Proportion Analysis by Market Taxonomy

15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.10.2.1. By Disease Indication

15.11. Nordic Countries Prostate Health Market Analysis

15.11.1. Value Proportion Analysis by Market Taxonomy

15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.11.2.1. By Disease Indication

15.12. China Prostate Health Market Analysis

15.12.1. Value Proportion Analysis by Market Taxonomy

15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.12.2.1. By Disease Indication

15.13. Japan Prostate Health Market Analysis

15.13.1. Value Proportion Analysis by Market Taxonomy

15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.13.2.1. By Disease Indication

15.14. South Korea Prostate Health Market Analysis

15.14.1. Value Proportion Analysis by Market Taxonomy

15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.14.2.1. By Disease Indication

15.15. GCC Countries Prostate Health Market Analysis

15.15.1. Value Proportion Analysis by Market Taxonomy

15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.15.2.1. By Disease Indication

15.16. South Africa Prostate Health Market Analysis

15.16.1. Value Proportion Analysis by Market Taxonomy

15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.16.2.1. By Disease Indication

15.17. Turkey Prostate Health Market Analysis

15.17.1. Value Proportion Analysis by Market Taxonomy

15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

15.17.2.1. By Disease Indication

15.17.3. Competition Landscape and Player Concentration in the Country

16. Market Structure Analysis

16.1. Market Analysis by Tier of Companies

16.2. Market Concentration

16.3. Market Share Analysis of Top Players

16.4. Market Presence Analysis

16.4.1. By Regional footprint of Players

16.4.2. Product footprint by Players

17. Competition Analysis

17.1. Competition Dashboard

17.2. Competition Benchmarking

17.3. Competition Deep Dive

17.3.1. GLAXOSMITHKLINE

17.3.1.1. Overview

17.3.1.2. Product Portfolio

17.3.1.3. Sales Footprint

17.3.1.4. Strategy Overview

17.3.2. ASTELLAS PHARMA

17.3.2.1. Overview

17.3.2.2. Product Portfolio

17.3.2.3. Sales Footprint

17.3.2.4. Strategy Overview

17.3.3. ALLERGAN

17.3.3.1. Overview

17.3.3.2. Product Portfolio

17.3.3.3. Sales Footprint

17.3.3.4. Strategy Overview

17.3.4. MERCK

17.3.4.1. Overview

17.3.4.2. Product Portfolio

17.3.4.3. Sales Footprint

17.3.4.4. Strategy Overview

17.3.5. ELI LILLY AND COMPANY

17.3.5.1. Overview

17.3.5.2. Product Portfolio

17.3.5.3. Sales Footprint

17.3.5.4. Strategy Overview

17.3.6. ABBOTT LABORATORIES

17.3.6.1. Overview

17.3.6.2. Product Portfolio

17.3.6.3. Sales Footprint

17.3.6.4. Strategy Overview

17.3.7. JOHNSON & JOHNSON SERVICES, INC.

17.3.7.1. Overview

17.3.7.2. Product Portfolio

17.3.7.3. Sales Footprint

17.3.7.4. Strategy Overview

17.3.8. ABBVIE

17.3.8.1. Overview

17.3.8.2. Product Portfolio

17.3.8.3. Sales Footprint

17.3.8.4. Strategy Overview

17.3.9. SANOFI

17.3.9.1. Overview

17.3.9.2. Product Portfolio

17.3.9.3. Sales Footprint

17.3.9.4. Strategy Overview

17.3.10. PFIZER, INC.

17.3.10.1. Overview

17.3.10.2. Product Portfolio

17.3.10.3. Sales Footprint

17.3.10.4. Strategy Overview

18. Assumptions and Acronyms Used

19. Research Methodology


Table 1: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 2: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 3: Global Prostate Health Market, By Region, 2015 – 2021

Table 4: Global Prostate Health Market, By Region, 2022 – 2032

Table 5: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 6: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 7: North America Prostate Health Market, By Country, 2015 – 2021

Table 8: North America Prostate Health Market, By Country, 2022 – 2032

Table 9: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 10: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 11: Latin America Prostate Health Market, By Country, 2015 – 2021

Table 12: Latin America Prostate Health Market, By Country, 2022 – 2032

Table 13: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 14: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 15: Europe Prostate Health Market, By Country, 2015 – 2021

Table 16: Europe Prostate Health Market, By Country, 2022 – 2032

Table 17: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 18: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 19: Asia Pacific Prostate Health Market, By Country, 2015 – 2021

Table 20: Asia Pacific Prostate Health Market, By Country, 2022 – 2032

Table 21: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 22: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 23: MEA Prostate Health Market, By Country, 2015 – 2021

Table 24: MEA Prostate Health Market, By Country, 2022 – 2032

Table 25: Global Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 26: Global Prostate Health Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 27: North America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 28: North America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 29: Latin America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 30: Latin America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 31: Europe Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 32: Europe Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 33: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 34: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 35: MEA Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 36: MEA Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032


Figure 1: Global Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Prostate Health Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 4: Global Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 5: Global Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 6: Global Prostate Health Market Share, By Region, 2022 & 2032

Figure 7: Global Prostate Health Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 8: Global Prostate Health Market Attractiveness Index, By Region – 2022-2032

Figure 9: North America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 10: North America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 11: North America Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 12: North America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 13: North America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 14: North America Prostate Health Market Share, By Country, 2022 & 2032

Figure 15: North America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 16: North America Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 17: Latin America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 18: Latin America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 19: Latin America Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 20: Latin America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 21: Latin America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 22: Latin America Prostate Health Market Share, By Country, 2022 & 2032

Figure 23: Latin America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 24: Latin America Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 25: Europe Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 26: Europe Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 27: Europe Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 28: Europe Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 29: Europe Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 30: Europe Prostate Health Market Share, By Country, 2022 & 2032

Figure 31: Europe Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 32: Europe Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 33: MEA Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 34: MEA Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 35: MEA Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 36: MEA Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 37: MEA Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 38: MEA Prostate Health Market Share, By Country, 2022 & 2032

Figure 39: MEA Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 40: MEA Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 41: Asia Pacific Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 42: Asia Pacific Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 43: Asia Pacific Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 44: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 45: Asia Pacific Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 46: Asia Pacific Prostate Health Market Share, By Country, 2022 & 2032

Figure 47: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 48: Asia Pacific Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 49: US Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 50: US Prostate Health Market Share, By Disease Indication, 2021

Figure 51: Canada Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 52: Canada Prostate Health Market Share, By Disease Indication, 2021

Figure 53: Brazil Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 54: Brazil Prostate Health Market Share, By Disease Indication, 2021

Figure 55: Mexico Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 56: Mexico Prostate Health Market Share, By Disease Indication, 2021

Figure 57: Germany Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 58: Germany Prostate Health Market Share, By Disease Indication, 2021

Figure 59: U.K. Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 60: U.K. Prostate Health Market Share, By Disease Indication, 2021

Figure 61: France Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 62: France Prostate Health Market Share, By Disease Indication, 2021

Figure 63: Italy Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 64: Italy Prostate Health Market Share, By Disease Indication, 2021

Figure 65: BENELUX Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 66: BENELUX Prostate Health Market Share, By Disease Indication, 2021

Figure 67: Nordic Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 68: Nordic Countries Prostate Health Market Share, By Disease Indication, 2021

Figure 69: China Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 70: China Prostate Health Market Share, By Disease Indication, 2021

Figure 71: Japan Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 72: Japan Prostate Health Market Share, By Disease Indication, 2021

Figure 73: South Korea Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 74: South Korea Prostate Health Market Share, By Disease Indication, 2021

Figure 75: GCC Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 76: GCC Countries Prostate Health Market Share, By Disease Indication, 2021

Figure 77: South Africa Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 78: South Africa Prostate Health Market Share, By Disease Indication, 2021

Figure 79: Turkey Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 80: Turkey Prostate Health Market Share, By Disease Indication, 2021

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Future Market Insights社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Future Market Insights社はどのような調査会社ですか?


Future Market Insights(FMI)は世界の広範な地域および産業を対象にした調査レポートを出版しています。  弊社ウェブサイトに掲載のないタイトルも全てお取り扱い可能ですので... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/05/02 10:26

146.99 円

166.15 円

197.83 円

ページTOPに戻る